Calcium signaling in prostate cancer cells: Evidence for multiple receptors and enhanced sensitivity to bombesin/GRP

Prostate

Volumn 30, Issue 3, 1997, Pages 167-173

  Wasilenko, William J ^a   Cooper, Jeffrey ^a   Palad, Ann J ^a   Somers, Kenneth D ^a   Blackmore, Peter F ^a   Rhim, Johng S ^b   Wright Jr , George L ^a   Schellhammer, Paul F ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

neuropeptides; purinergic receptors; signal transduction

Indexed keywords

ADENOSINE TRIPHOSPHATE; BOMBESIN; PURINE P2 RECEPTOR; URIDINE TRIPHOSPHATE;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CANCER GROWTH; GROWTH REGULATION; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR BINDING; SECOND MESSENGER;

BOMBESIN; CALCIUM; CALCIUM CHANNELS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; NEUROPEPTIDES; PROSTATIC NEOPLASMS; RECEPTORS, BOMBESIN; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0030889867     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19970215)30:3<167::AID-PROS4>3.0.CO;2-J     Document Type: Article

References (49)

1. Labrie FA, Dupont A, Belanger A: Complete androgen blockade for the treatment of prostate cancer. In DeVita VT Jr, Hellman S, Rosenberg SA (eds): "Important Advances in Oncology." Philadelphia: JP Lippincott, 1983, pp 193-217.
2. Isaacs JT, Schulze H, Coffey DS: Development of androgen resistance in prostatic cancer. In Murphy GP, Khoury S, Kuss IR, Chatelain C, Denis L (eds): "Prostate Cancer, Part A: Research, Endocrine Treatment, and Histopathology." New York: Alan R. Liss, Inc., 1987, pp 21-31.
3. Myers C, Trepel J, Sartor O, Cooper M, Ransom M, Toko T, Linehan MW: Antigrowth factor strategies. Cancer (suppl) 71:1172-1178, 1993.
4. Steiner MS: Role of peptide growth factors in the prostate: a review. Urology 42:99-110, 1993.
5. Berridge MJ: Inositol trisphosphate and calcium signalling. Nature 361:315-325, 1993.
6. Clapham D: Calcium signaling. Cell 80:259-268, 1995.
7. Taylor CW, Marshall ICB: Calcium and inositol 1,4,5-trisphosphate receptors: a complex relationship. Trends Biochem Sci 17:403-407, 1992.
8. Putney JWJ: Capacitative calcium entry revisited. Cell Calcium 11:611-624, 1990.
9. Cole K, Kohn E: Calcium-mediated signal transduction: biology, biochemistry, and therapy. Cancer Metastasis Rev 13:31-44, 1994.
10. Means AR: Calcium, calmodulin and cell cycle regulation. FEBS Lett 347:1-4, 1994.
11. 2+ pool content is linked to control of cell growth. Proc Natl Acad Sci USA, 90:4986-4990, 1993.
12. Savarese DMF, Russel JT, Fatatis A, Liotta LA: Type IV collagen stimulates an increase in intracellular calcium: potential role in tumor cell motility. J Biol Chem 267: 21928-21935, 1992.
13. Kohn E, Allessandro R, Spoonster J, Wersto R, Liotta L: Angiogenesis: role of calcium-mediated signal transduction. Proc Natl Acad Sci USA 92:1307-1311, 1995.
14. Nicotera P, Zhivotovsky B, Orrenius S: Nuclear calcium transport and the role of calcium in apoptosis. Cell Calcium 16:279-288, 1994.
15. Powis G, Phil D: Inhibitors of phosphatidylinositol signalling as antiproliferative agents. Cancer Metastasis Rev 13:91-105, 1994.
16. Kohn EC, Felder CC, Jacobs W, Holmes KA, Day A Freer R, Liotta LA: Structure-function analysis of signal and growth inhibition by carboxyamido-triazole, CAI. Cancer Res 54:935-942, 1994.
17. Kohn EC, Sandeen MA, Liotta LA: In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates. Cancer Res 52:3208-3212, 1992.
18. Kohn EC, Liotta LA: L651582, a novel antiproliferative and antimetastasis agent. J Natl Cancer Inst, 82:54-60, 1990.
19. Chen TR: Chromosome identity of human prostate cancer cell lines PC-3 and PPC-1. Cytogenet Cell Genet 62:183-184, 1993.
20. Van Steenbrugge GJ, Groen M, VanDongen JW Bolt J, Van der Korput H, Trapman J, Hasenson M, Horoszewicz J: The human prostatic carcinoma cell line LNCaP and its derivatives. An overview. Urol Res 17:71-77, 1989.
21. Lee MS, Garkovenko E, Yun JS, Weijerman PC, Peehl DM Chen LS, Rhim JS: Characterization of adult human prostatic epithelial cells immortalized by polybrene-induced DNA transfection with a plasmid containing a origin-defective SV 40 genome. Int J Oncol 4:821-830, 1994.
22. Blackmore PF, Oakes SG, Somers KD: Altered H1 histamine receptor signaling in Balb/3T3 cells transformed by v-K-ras and v-H-ras oncogenes. Oncogene 7:2053-2057, 1992.
23. Lebacq-Verheyden AM, Trepel J, Sausville EA, Battey JF: Bombesin and gastrin-releasing peptide: neuropeptides, secretagogues, and growth factors. In Sporn MB, Roberts AB (eds): "Peptide Growth Factors and Their Receptors II." New York: Springer-Verlag, 1990, pp 71-124.
24. Sethi T, Langdon S, Smyth J, Rozengurt E: Growth of small cell lung cancer cells: stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo. Cancer Res (suppl) 52:2737-2742, 1992.
25. di Sant' Agnese PA: Neuroendocrine differentiation in carcinoma of the prostate. Cancer 70:254-268, 1992.
26. Wang D, Huang N, Heller E, Heppel L: A novel synergistic stimulation of Swiss 3T3 cells by extracellular ATP and mitogens with opposite effects on cAMP levels. J Biol Chem 269:16648-16655, 1994.
27. 4] bombesin by tumor cells. Prostate 25:29-38, 1994.
28. 2-purinergic receptors: subtype-associated signaling responses and structure. Annu Rev Pharmacol Toxicol 35:541-579, 1995.
29. Kiley S, Jaken S: Protein kinase C: interactions and consequences. Trends Cell Biol 4:223-226, 1994.
30. Roberts M: First thoughts on lipid second messengers. Trends Cell Biol 4:219-223, 1994.
31. Gusovsky F, Lueders JE, Kohn EC, Felder CC: Muscarinic receptor-mediated tyrosine phosphorylation of phospholipase C-γ: an alterative mechanism for cholinergic-induced phosphoinositide breakdown. J Biol Chem 268:7768-7772, 1993.
32. Filvaroff E, Calautti E, Reiss M, Dotto GP: Functional evidence for an extracellular calcium receptor mechanism triggering tyrosine kinase activation associated with mouse keratinocyte differentiation. J Biol Chem 269:21735-21740, 1994.
33. Negulescu PA, Shastri N, Cahalan MD: Intracellular calcium dependence of gene expression in single T lymphocytes. Proc Natl Acad Sci USA 91:2873-2877, 1994.
34. Bading H, Ginty DD, Greenberg ME: Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science 60:181-186, 1993.
35. Takuwa N, Takuwa Y, Ohue Y, et al: Stimulation of calcium mobilization but not proliferation by bombesin and tachykinin neuropeptides in human small cell lung cancer cell lines. Cancer Res 50:240-244, 1990.
36. Bologna M, Festuccia C, Muzi PI, Biordi L, Ciomei M: Bombesin stimulates growth of human prostatic cancer cells in vitro. Cancer 63:1714-1720, 1989.
37. Pinski J, Schally AV, Halmos G, Szepeshazi K: Effect of somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate cancer xenografts in nude mice. Int J Cancer 55:963-967, 1993.
38. Pinski J, Halmos G, Schally AV: Somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostate cancer line in nude mice. Cancer Lett 71:189-196, 1993.
39. Milovanovic S, Radulovic S, Groot K, Schally AV: Inhibition of growth of PC-82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC-3095 or combination of agonist (D-Trp-6)-LH-RH and somatostatin analog RC-160. Prostate 20:269-280, 1992.
40. Frankel A, Tsao M, Viallet J: Receptor subtype expression and responsiveness to bombesin in cultured human bronchial epithelial cells. Cancer Res 54:1613-1616, 1994.
41. Huang ND, Wang DJ, Heppel LA: Extracellular ATP is a mitogen for 3T3, 3T6, and A431 cells and acts synergistically with other growth factors. Proc Natl Acad Sci USA 86:7904-7908, 1989.
42. 2-purinergic receptor agonists inhibit the growth of androgen-independent prostate carcinoma cells. J Clin Invest 89:191-196, 1992.
43. Hoosein N, Logothetis C, Chung L: Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells. J Urol 149:1209-1213, 1993.
44. Yoshida E, Verrusio E, Mihara H, Oh D, Kwaan H: Enhancement of the expression of urokinase-type plasminogen activator from PC-3 human prostate cancer cells by thrombin. Cancer Res 54:3300-3304, 1994.
45. 1 receptors. J Cell Biol 110:1211-1215, 1990.
46. Liebow C, Crean D, Lee M, Kamer A, Mang T, Schally A: Synergistic effects of bombesin and epidermal growth factor on cancers. Proc Natl Acad Sci USA 91: 3804-3808, 1994.
47. Kobayashi S, Tang R, Wang B, Opgenorth T, Langenstroer P, Shapiro E, Lepor H: Binding and functional properties of endothelin receptor subtypes in the human prostate. Mol Pharmacol 45:306-311, 1994.
48. Kusuhara M, Yamaguchi K, Nagasaki K, Hayashi C, Suzaki A, Hori S, Handa S, Nakamura Y, Abe K: Production of endothelin in human cancer cell lines. Cancer Res 50:3257-3261, 1990.
49. Bunn PA Jr, Chan D, Dienhart DG, Rolley R, Tolley R, Tagawa M, Jewett P: Neuropeptide signal transduction in lung cancer: clinical implications of bradykinin sensitivity and overall heterogeneity. Cancer Res 52:24-31, 1992.